1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics

Mental Health Analysis & Statistics

1-30 of 32 reports

Alcohol Use Disorder - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 76 pages

‘Alcohol Use Disorder - Epidemiology Forecast–2032’ report delivers an in-depth understanding of the Alcohol Use Disorder, historical and forecasted epidemiology as well as the Alcohol Use Disorde ...

  • United States
  • Spain
  • Addiction Disorder
  • Industry analysis
  • Alcohol Excessive Use

Deep Brain Stimulation Devices–Pipeline Insight and Competitive Landscape, 2022

  • $ 2250
  • July 2022
  • 60 pages

“Deep Brain Stimulation Devices–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in deep brain stimulation (DBS) devices pipeline landscape. ...

  • World
  • Neurological Disorder
  • Industry analysis

Electroencephelographs (EEG)–Pipeline Insight and Competitive Landscape, 2022

  • $ 2250
  • July 2022
  • 60 pages

“Electroencephelographs (EEG)–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape. Increased ...

  • United States
  • World
  • Neurological Disorder
  • Psychotic Disorder
  • Industry analysis

Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 172 pages

" Developmental and Epileptic Encephalopathy - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the DEE, historical and forecasted epidemiology as well as the DEE market trends ...

  • Germany
  • Spain
  • Neurological Disorder
  • Industry analysis

Anorexia - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 53 pages

‘Anorexia Nervosa (AN)- Epidemiology Forecast–2032’ report delivers an in-depth understanding of AN, historical and forecasted epidemiology as well as AN trends in the United States, EU5 (Germany, ...

  • Spain
  • Japan
  • Eating Disorder
  • Industry analysis

Post-Traumatic Stress Disorder (PTSD) - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 67 pages

" Post-traumatic stress disorder (PTSD) - Epidemiology Forecast-2032" report delivers an in-depth understanding of the Post-traumatic stress disorder (PTSD), historical and forecasted epidemiology as well ...

  • Spain
  • France
  • Anxiety Disorder
  • Industry analysis

Fabry Disease - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 90 pages

‘Fabry Disease—Epidemiology Forecast—2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Fabry Disease in the United States, EU5 (Germany, Spain, Italy, ...

  • Spain
  • Germany
  • Neurological Disorder
  • Industry analysis

Myasthenia Gravis - Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 60 pages

“Myasthenia Gravis – Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Myasthenia Gravis pipeline landscape. It covers the pipeline drug ...

  • World
  • Japan
  • Neurological Disorder
  • Therapy
  • Industry analysis

Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 80 pages

“Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Acetylcholine Receptor (AChR) Antagonists pipeline ...

  • World
  • Therapy
  • Depression
  • Industry analysis

Tau Inhibitors - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 80 pages

“Tau Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Tau Inhibitors pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Therapy
  • Dementia
  • Industry analysis

Alcohol Use Disorder (AUD) - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • September 2022
  • 152 pages

‘Alcohol Use Disorder - Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Alcohol Use Disorder, historical and forecasted epidemiology as well ...

  • United States
  • Japan
  • Addiction Disorder
  • Industry analysis
  • Alcohol Excessive Use
  • Drug Approval

Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 345 pages

" Developmental and Epileptic Encephalopathy - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DEE, historical and forecasted epidemiology as well ...

  • United States
  • Japan
  • Therapy
  • Neurological Disorder
  • Industry analysis
  • Drug Approval
  • Inflation Rate

Anorexia - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 107 pages

‘Anorexia nervosa-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the anorexia nervosa, historical and forecasted epidemiology as well as the ...

  • United States
  • Spain
  • Eating Disorder
  • Industry analysis
  • Depression Prevalence

Post-Traumatic Stress Disorder (PTSD) - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 135 pages

"Post-traumatic stress disorder (PTSD) - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Post-traumatic stress disorder (PTSD), historical and ...

  • Japan
  • United States
  • Anxiety Disorder
  • Industry analysis
  • Health Expenditure

Fabry Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 181 pages

‘Fabry Disease—Market Insights, Epidemiology, and Market Forecast—2032’ report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Fabry ...

  • Japan
  • United States
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Dravet Syndrome - Pipeline Insight, 2022

  • $ 1500
  • March 2022
  • 50 pages

“Dravet Syndrome - Pipeline Insight, 2022,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Dravet Syndrome pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • United States
  • Neurological Disorder
  • Industry analysis
  • Mortality Rate

X linked Adrenoleukodystrophy - Pipeline Insight, 2022

  • $ 1500
  • March 2022
  • 60 pages

“X linked Adrenoleukodystrophy- Pipeline Insight, 2022,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in X linked Adrenoleukodystrophy pipeline landscape. It covers ...

  • World
  • Neurological Disorder
  • Therapy
  • Industry analysis

Lipoxygenase Inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 80 pages

“Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Lipoxygenase Inhibitor (LOX Inhibitor) pipeline ...

  • World
  • Therapy
  • Clinical Development
  • Industry analysis

RIPK1 Inhibitor - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“RIPK1 inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 6+ pipeline drugs in RIPK1 inhibitor pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Therapy
  • Dementia
  • Industry analysis

LRRK2 Inhibitor - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Leucine-Rich Repeat Kinase (LRRK)-2 Inhibito ...

  • World
  • Clinical Development
  • Psychotic Disorder
  • Industry analysis

GABA A receptor agonist - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“GABA A receptor agonist - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in GABA A receptor agonist pipeline landscape. It covers the pipeline ...

  • World
  • Therapy
  • Anesthetics
  • Industry analysis

Amyloid beta-protein inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Amyloid Beta-Protein Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Amyloid Beta-Protein Inhibitors pipeline landscape. It ...

  • World
  • Dementia
  • Therapy
  • Industry analysis

Alpha-Synuclein (alphaSyn or SNCA) Inhibitor - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Alpha-Synuclein (alphaSyn or SNCA) Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in Alpha-Synuclein (alphaSyn or SNCA) Inhibito ...

  • World
  • Therapy
  • Psychotic Disorder
  • Industry analysis

5-HT2A Agonists - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“5-HT2A Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in 5-HT2A Agonists pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Therapy
  • Drug Development
  • Industry analysis

Tau protein inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Tau protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Tau protein inhibitors pipeline landscape. It covers the pipeline ...

  • World
  • Dementia
  • Therapy
  • Industry analysis

Dihydroorotate dehydrogenase inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Dihydroorotate Dehydrogenase (DHODH) Inhibito ...

  • World
  • Therapy
  • Clinical Development
  • Industry analysis

T type calcium channel antagonists - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“T Type Calcium Channel Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in T Type Calcium Channel Antagonists pipeline landscape. ...

  • World
  • Therapy
  • Calcium Channel Blocker
  • Industry analysis

Alpha-synuclein inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Alpha-Synuclein Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Alpha-Synuclein Inhibitors pipeline landscape. It covers the ...

  • World
  • Therapy
  • Psychotic Disorder
  • Industry analysis

Amyloid precursor protein secretase inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Amyloid precursor protein secretase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Amyloid precursor protein secretase inhibitors ...

  • World
  • Therapy
  • Dementia
  • Industry analysis

Histone Deacetylase 6 (HDAC 6) inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Histone Deacetylase 6 (HDAC 6) inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Histone Deacetylase 6 (HDAC 6) inhibitors pipeline ...

  • World
  • Therapy
  • Neurological Disorder
  • Industry analysis

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on